Sara Kopolow
Senior Research Director
Sara has 15 years of qualitative research and strategy experience helping pharmaceutical and biotech companies harness customer insight to drive brand growth. Her ability to seamlessly blend empathy, curiosity, creativity, and strategic thinking has been pivotal to the successful delivery of actionable insights and strategies across all stages of the product lifecycle.
Sara has led a variety of US and global qualitative research and strategy projects, including customer journeys, positioning development and testing, and creative testing. While her most recent therapeutic area experience has focused in rare disease, she has worked in neurology, immunology, psychiatry, rheumatology, ophthalmology, and oncology.
People describe Sara as charismatic, collaborative, enthusiastic, and thoughtful.
Key achievements
- Developed a global masterbrand positioning with an indication-specific supporting architecture for a rare autoimmune disease drug
- Pioneered a new, visually compelling way to present customer journeys
- Recognized as a top new business generator for the multi-million-dollar growth of a net-new client account
- Identified and solidified the opportunity for a rare autoimmune disease drug to expand into a disease sub-type, filling an unmet need for patients and HCPs and strengthening the company’s foothold in neuromuscular disease
- Illuminated key patient and HCP insights to strategically shape the launch of SPRAVATO®, a nasal spray for adults with treatment-resistant depression
Roles and qualifications
- Previous director-level roles at Egg Strategy and Brado
- Graduate of Washington University’s Mini-Med. School, a series of lectures and hands-on training sessions taught by faculty and residents
- RIVA trained in Fundamentals of Moderating
- Graduate of Miami Ad School’s Account Planning Bootcamp, an immersion into creative strategy with top industry strategy professionals
Connect with Sara on Linked In